Nobivac for Canine 1-DAPPv+Cv (25 Doses) - [Vaccine]

Nobivac Canine 1-DAPPv+Cv recommended for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine distemper virus, adenovirus type 1 (hepatitis), adenovirus type 2 (respiratory disease), canine parainfluenza virus, canine parvovirus, and coronavirus.

Canine Distemper, Adenovirus Type 2, Coronavirus, Parainfluenza, Parvovirus Vaccine, MODIFIED LIVE AND KILLED VIRUS Proven 1-year combination vaccine that offers broad protection for dogs against parvovirus, coronavirus, distemper, adenovirus types 1 and 2, and parainfluenza.

Protects against all known strains of canine parvovirus (CPV), including CPV-2c^1-3

Contains CPV-2b, one of the most prevalent field strains of parvovirus

High antigenic mass (titer), low passage

Multiple studies demonstrate the ability to override maternal antibodies.³

Protects against 2 types of adenovirus that cause hepatitis and respiratory disease in dogs

Provides disease coverage for commonly spread canine viruses, coronavirus, distemper, adenovirus types 1 and 2, parainfluenza and parvovirus, in 1 formula

Indications

Approved for the vaccination of healthy dogs as an aid in the precention of disease caused by canine distemper virus, adenovirus types 1 and 2, parainfluenza, and parvovirus

Recommended for use in healthy dogs 6 weeks of age or older

Shake the Nobivac Canine 1-Cv vial and transfer its contents to the Nobivac Canine 1-DAPPv vial aeptically. Mix gently until dissolved. Use entire contents immediately after rehydration.

Inject one dose (1ml) subcutaneously or intramuscularly. The initial dose may be given at 6 weeks of age or older. Repeat at 2 to 4 week intervals until the dog is 12 weeks of age. A minimum of two doses is required for primary immunization. Annual revaccination with one dose is recommended. Following the advice of the American Veterinary Medical Association on Vaccination PRinciples, an appropriate revaccination program for individual animals should be made based upon veterinarian-client-patient relationships.

Subcutaneous or intramuscular injection

Two 1ml doses given 2-4 weeks apart

Repeat at 2-4 week intervals until the dog is 12 weeks of age

Annual revaccination with 1 dose is recommended: Following the advice of The American Veterinary Medical Association on Vaccination Principles, an appropriate revaccination program for individual animals should be based upon veterinarian-client patient relationships.

SAFETY INFORMATION: Please see the product label for safety information.

PRECAUTIONS:

Store at 2°-7°

Do not freeze.

Do not mix with other vaccines.

Use new, non-chemically sterilized needles and syringes.

Burn vaccine container and all unused contents.

WARNINGS:

Contains gentamicin as a preservative.

Vaccinate only health, non-parasitized dogs.

Do not vaccinate pregnant bitches.

The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions. Antidote: Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.

The age at which maternal antibody for canine parvovirus no longer interferes with the development of active immunity varies according to the bitch's titer and quantity of colostral antibodies absorbed by the puppy.